Effect of N-Acetylcysteine (NAC) on Creatinine in Chronic Kidney Disease

PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

October 31, 2007

Primary Completion Date

October 31, 2008

Study Completion Date

October 31, 2008

Conditions
Chronic Kidney Disease
Interventions
DRUG

N-acetylcysteine

N-acetylcysteine 1200 mg twice daily x 48 hours

DRUG

Placebo

Trial Locations (1)

N6A 5W9

London Health Sciences Centre, London

All Listed Sponsors
collaborator

The Physicians' Services Incorporated Foundation

OTHER

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT00506506 - Effect of N-Acetylcysteine (NAC) on Creatinine in Chronic Kidney Disease | Biotech Hunter | Biotech Hunter